Cardioprotection and the mitochondrial permeability transition

Minerva Cardioangiologica

Volumn 58, Issue 2, 2010, Pages 241-251

  Keith, R J ^a   Bhatnagar, A ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Cardiovascular diseases; Cell death; Myocardial ischemic reperfusion injury

Indexed keywords

APOPTOSIS; CARDIOVASCULAR DISEASE; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DIABETES MELLITUS; EPIDEMIC; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; INCIDENCE; MITOCHONDRIAL PERMEABILITY; MORTALITY; OBESITY; PREVALENCE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL DEATH; HUMANS; INTRACELLULAR MEMBRANES; MITOCHONDRIA; MYOCARDIAL REPERFUSION INJURY; PERMEABILITY;

EID: 77954699120     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. The Atlas of Heart Disease and Stroke [computer program]. Bethesda, MD2008.
2. Rosamond W, Flegal K, Furie K, Furie K, Go A, Greenlund K et al. Heart disease and stroke statistics - 2008 update - A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:e69-171. (Pubitemid 46226160)
3. Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart 2002;88:119-24. (Pubitemid 34787755)
4. Javadov S, Karmazyn M, Escobales N. Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases. J Pharmacol Exp Ther Sep 2009;330:670-8.
5. Kroemer G, Dallaporta B, Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. [Review] [95 refs]. Ann Rev Physiol 1998;60:619-42.
6. Crompton M, Costi A, Hayat L. Evidence for the presence of a reversible Ca2+-dependent pore activated by oxidative stress in heart mitochondria. Biochem J 1987;245:915-8.
7. Halestrap AP, Doran E, Gillespie JP, O'Toole A. Mitochondria and cell death. Biochem Soc Trans Feb 2000;28:170-7.
8. Iverson SL, Orrenius S. The cardiolipin-cytochrome c interaction and the mitochondrial regulation of apoptosis. Arch Biochem Biophys 2004;423:37-46.
9. Scarlett JL, Murphy MP. Release of apoptogenic proteins from the mitochondrial intermembrane space during the mitochondrial permeability transition. FEBS Lett 1997;418:282-6.
10. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med 2000;6:513-9.
11. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007;87:99-163. (Pubitemid 46209992) (Pubitemid 46209992)
12. Di Lisa F, Canton M, Menabò R, Kaluderdc N, Bernardi P. (Document ID: 1308565421). Mitochondria and cardioprotection. Heart Failure Reviews 2007;12:249-60.
13. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection. Cardiovasc Res 2004;61:372-85.
14. Baines CP, Kaiser RA, Sheiko T, Craigen WJ, Molkentin JD. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol 2007;9:550-5.
15. Kokoszka JE, Waymire KG, Levy SE, Sligh JE, Cai J, Jones DP et al. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 2004;427:461-5.
16. Basso E, Fante L, Fowlkes J, Petronilli V, Forte MA, Bernardi P. Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D. J Biol Chem 2005;280:18558-61.
17. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA et al. Loss of cydophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005;434:658-62.
18. Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005;434:652-8.
19. Goldstein JC, Waterhouse NJ, Juin P, Evan GI, Green DR. The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nature Cell Biology 2000;2:156-62.
20. Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD et al. Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol 1999;144:281-92.
21. Leung AW, Varanyuwatana P, Halestrap AP. The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition. J Biol Chem 2008;283:26312-23.
22. Halestrap AP, Woodfield KY, Connern CP. Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J Biol Chem 1997;272:3346-54.
23. Basso E, Petronilli V, Forte MA, Bernardi P. Phosphate is essential for inhibition of the mitochondrial permeability transition pore by cyclosporin A and by cyclopbilin D ablation. J Biol Chem 2008;283:26307-11.
24. Honda HM, Ping P. Mitochondrial permeability transition in cardiac cell injury and death. [Review] [69 refs]. Cardiovasc Drugs Ther 2006:425-32.
25. Weiss JN, Korge P, Honda HM, Ping P. Role of the mitochondrial permeability transition in myocardial disease. [Review] [94 refs]. Circul Res 2003;93:292-301.
26. Scorrano L, Ashiya M, Buttle K, Weiler S, Oakes SA, Mannella CA et al. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev Cell 2002;2:55-67. (Pubitemid 34065906)
27. Petit PX, Goubern M, Diolez P, Susin SA, Zamzami N, Kroemer G. Disruption of the outer mitochondrial membrane as a result of large amplitude swelling: the impact of irreversible permeability transition. FEBS Lett 1998;426:111-6.
28. Green DR, Reed JC. Mitochondria and apoptosis. [Review] [59 refs]. Science 1998;281:1309-12.
29. Hunter DR, Haworth RA. Ca-2+-induced membrane transition in mitochondria .3. transitional ca-2+ release. Arch Biochem Biophys 1979;195:468-77.
30. Hunter DR, Haworth RA. Ca-2+-induced membrane transition in mitochondria .1. protective mechanisms. Arch Biochem Biophys 1979;195:453-9.
31. Hunter DR, Haworth RA, Southard JH. Relationship between configuration, function, and permeability in calcium-treated mitochondria. J Biol Chem 1976;251:5069-77.
32. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. [Review] [224 refs]. Am J Physiol Cell Physiol 2004;287:C817-33.
33. Lynn EG, Lu Z, Minerbi D, Sack MN. The regulation, control, and consequences of mitochondrial oxygen utilization and disposition in the heart and skeletal muscle during hypoxia. [Review] [99 refs]. Antioxid Redox Signal 2007;9:1353-61.
34. Robin E, Guzy RD, Loor G, Iwase H, Waypa GB, Marks JD et al. Oxidant stress during simulated ischemia primes cardiomyocytes for cell death during reperfusion. J Biol Chem 2007;282:19133-43.
35. Misra MK, Sarwat M, Bhakuni P, Tuteja R, Tuteja N. Oxidative stress and ischemic myocardial syndromes. Med Sci Monit 2009;15:RA209-219.
36. Hack B, Witting PK, Rayner BS, Stocker R, Headrick JP. Oxidant stress and damage in post-ischemic mouse hearts: effects of adenosine. Mol Cell Biochem 2006;287:165-75. (Pubitemid 44057404)
37. Fuller W, Parmar V, Eaton P, Bell JR, Shattock MJ. Cardiac ischemia causes inhibition of the Na/K ATPase by a labile cytosolic compound whose production is linked to oxidant stress. Cardiovasc Res 2003;57:1044-51.
38. Eaton P, Hearse DJ, Shattock MJ. Lipid hydroperoxide modification of proteins during myocardial ischaemia. Cardiovasc Res 2001;51:294-303. (Pubitemid 32695540)
39. McPherson BC, Zhu X, Liu H, Wang B, Baman T, McPherson SS et al. Acetylcholine attenuates cardiomyocyte oxidant stress during simulated ischemia and reoxygenation. Pharmacology 2002;64:49-56.
40. Iwakura A, Fujita M, Hasegawa K, Toyokuni S, Sawamura T, Nohara R et al. Pericardial fluid from patients with ischemic heart disease induces myocardial cell apoptotis via an oxidant stress-sensitive p38 mitogen-activated protein kinase pathway. J Mol Cell Cardiol 2001;33:419-30.
41. Griffiths EJ, Halestrap AP. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 1995;307:93-8.
42. Muny CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36.
43. Banerjee S, Tang XL, Qiu Y, Takano H, Manchikalapudi S, Dawn B et al. Nitroglycerin induces late preconditioning against myocardial stunning via a PKC-dependent pathway. Am J Physiol 1999;277(6 Pt 2):H2488-94.
44. Sun JZ, Tang XL, Park SW, Qiu Y, Turrens JF, Bolli R. Evidence for an essential role of reactive oxygen spedes in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest 1996;97:562-76. (Pubitemid 26039424)
45. Takano H, Manchikalapudi S, Tang XL, Qiu Y, Rizvi A, Jadoon AK et al. Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Circulation 1998;98:441-9.
46. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003;285:H579-588. (Pubitemid 36885888)
47. Preckel B, Schlack W, Comfere T, Obal D, Barthel H, Thamer V. Effects of enflurane, isoflurane, sevoflurane and desflurane on reperfusion injury after regional myocardial ischaemia in the rabbit heart in vivo. Br J Anaesth 1998;81:905-912. (Pubitemid 28561325) (Pubitemid 28561325)
48. Argaud L, Gateau-Roesch O, Raisky O, Loufouat J, Robert D, Ovize M. Postconditioning inhibits mitochondrial permeability transition. Circulation 2005;111:194-7.
49. Lim SY, Davidson SM, Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore. Cardiovasc Res 2007;75:530-5.
50. Wang C, Neff DA, Krolikowski JG, Weihrauch D, Bienengraeber M, Warltier DC et al. The influence of B-cell lymphoma 2 protein, an antiapoptotic regulator of mitochondrial permeability transition, on isoflurane-induced and ischemic postconditioning in rabbits. Anesth Analg 2006;102:1355-60.
51. Javadov SA, Clarke S, Das M, Griffiths EJ, Lim KH, Halestrap AP. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J Physiol 2003;549(Pt 2):513-24. (Pubitemid 36701762)
52. Bolli R, Dawn B, Tang XL, Qiu Y, Ping P, Xuan YT et al. The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol 1998;93:325-38.
53. Jones SP, Bolli R. The ubiquitous role of nitric oxide in cardioprotection. J Mol Cell Cardiol 2006;40:16-23.
54. Li Q, Guo Y, Xuan YT, Lowenstein CJ, Stevenson SC, Prabhu SD et al. Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism. Circ Res 2003;92:741-8.
55. West MB, Rokosh G, Obal D, Velayutham M, Xuan YT, Hill BG et al. Cardiac myocyte-specific expression of inducible nitric oxide synthase protects against ischemia/reperfusion injury by preventing mitochondrial permeability transition. Circulation 2008;118:1970-8.
56. Feng J, Lucchinetti E, Ahuja P, Pasch T, Perriard J-C, Zaugg M. Isoflurane Postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3[beta]. Anesthesiology 2005;103:987-95.
57. Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW et al. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 2004;113:1535-49.
58. Bopassa JC, Ferrera R, Gateau-Roesch O, Couture-Lepetit E, Ovize M. PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning. Cardiovasc Res 2006;69:178-85.
59. Davidson SM, Hausenloy D, Duchen MR, Yellon DM. Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection. Int J Biochem Cell Biol 2006;38:414-9.
60. Cohen MV, Yang XM, Downey JM. The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation2007;115:1895-903.
61. Sun HY, Wang NP, Kerendi F, Halkos M, Kin H, Guyton RA et al. Hypoxic postconditioning reduces cardiomyocyte loss by inhibiting ROS generation and intracellular Ca2+ overload. Am J Physiol Heart Circ Physiol 2005;288:H1900-1908.
62. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 1993;87:893-9.
63. Konstantinov IE, Li J, Cheung MM, Shimizu M, Stokoe J, Kharbanda RK et al. Remote ischemic preconditioning of the redpient reduces myocardial ischemia-reperfusion injury of the denervated donor heart via a Katp channel-dependent mechanism. Transplantation 2005;79:1691-5.
64. Heidbreder M, Naumann A, Tempel K, Dominiak P, Dendorfer A. Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways. Cardiovasc Res 2008;78:108-15. (Pubitemid 351430955)
65. Pell TJ, Baxter GF, Yellon DM, Drew GM. Renal ischemia preconditions myocardium: role of adenosine receptors and ATP-sensitive potassium channels. Am J Physiol 1998;275(5 Pt 2):H1542-1547.
66. Birnbaum Y, Hale SL, Kloner RA. Ischemic preconditioning at a distance: reduction of myocardial infarct size by partial redudion of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. Circulation 1997;96:1641-6. (Pubitemid 27375364)
67. Gho BC, Schoemaker RG, van den Doel MA, Duncker DJ, Verdouw PD. Myocardial protection by brief ischemia in noncardiac tissue. Circulation 1996;94:2193-200.
68. Kharbanda RK, Mortensen UM, White PA, Kristiansen SB, Schmidt MR, Hoschtitzky JA et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 2002;106:2881-3.
69. Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J et al. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol 2006;47:2277-82.
70. Venugopal V, Hausenloy DJ, Ludman A, Di Salvo C, Kolvekar S, Yap J et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: a randomised controlled trial. Heart 2009;95:1567-71.
71. Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, Grundy E et al. Effed of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 2007;370:575-9.
72. Ali ZA, Callaghan CJ, Lim E, Ali AA, Nouraei SA, Akthar AM et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation 2007;116(11 Suppl):I98-105.
73. Perrault LP, Menasche P, Bel A, de Chaumaray T, Peynet J, Mondry A et al. Ischemic preconditioning in cardiac surgery: a word of caution. J Thorac Cardiovasc Surg 1996;112:1378-86.
74. Cremer J, Steinhoff G, Karck M, Ahnsell T, Brandt M, Teebken OE et al. Ischemic preconditioning prior to myocardial protection wtth cold blood cardioplegia in coronary surgery. Eur J Cardiothorac Surg 1997;12:753-8. (Pubitemid 28035540)
75. Illes RW, Swoyer KD. Prospective, randomized clinical study of ischemic preconditioning as an adjunct to intermittent cold blood cardioplegia. Ann Thorac Surg 1998;65:748-52.
76. Wu ZK, Tarkka MR, Pehkonen E, Kaukinen L, Honkonen EL, Kaukinen S. Beneficial effects of ischemic preconditioning on right ventricular function after coronary artery bypass grafting. Ann Thorac Surg 2000;70:1551-7.
77. Lu EX, Chen SX, Yuan MD, Hu TH, Zhou HC, Luo WJ et al. Preconditioning improves myocardial preservation in patients undergoing open heart operations. Ann Thorac Surg 1997;64:1320-4.
78. Teoh LK, Grant R, Hulf JA, Pugsley WB, Yellon DM. The effed of preconditioning (ischemic and pharmacological) on myocardial necrosis following coronary artery bypass graft surgery. Cardiovasc Res 2002;53:175-80.
79. Gomez L, Li B, Mewton N, Sanchez I, Piot C, Elbaz M et al. Inhibition of mitochondrial permeability transition pore opening: translation to patients. Cardiovasc Res 2009;83:226-33.
80. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L'Huillier I et al. Postconditioning the human heart. Circulation 2005;112:2143-8.
81. Thibault H, Piot C, Staat P, Bontemps L, Sportouch C, Rioufol G et al. Long-term benefit of postconditioning. Circulation 2008;117:1037-44.
82. Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N et al. Effed of cydosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 2008;359:473-81.
83. Shanmuganathan S, Hausenloy DJ, Duchen MR, Yellon DM. Mitochondrial permeability transition pore as a target for cardioprotection in the human heart. Am J Physiol Heart Circ Physiol 2005;289:H237-242.
84. Hausenloy DJ, Yellon DM. New directions for proteding the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 2004;61:448-60.
85. Hausenloy DJ, Yellon DM. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev 2007;12:217-34.
86. Bhamra G, Hausenloy D, Davidson S, Carr RD, Paiva M, Wynne AM et al. Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening. Basic Res Cardiol 2008;103:274-84.